About EyeCRO
EyeCRO is a Healthcare company based in Oklahoma City (United States) founded in 2011. Provider of in vivo and in vitro models for ophthalmic research. EyeCRO offers products and services including MiDROPS®, Preclinical Models, and Toxicology Services. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Ophthalmology. Its competitors include Lexitas, Humonix Biosciences and Optimal Tracers.
Company details
EyeCRO is a preclinical ophthalmic CRO whose primary offerings are retinal disease models. They specialize in ophthalmic studies of pharmacology, toxicology, efficacy, pharmacokinetics, and eyedrop formulation development. They offer their services in preclinical development areas such as formulation, study design, ocular surgery, veterinary, cell biology, and molecular biology. Their patent protected Microemulsion Drug Ocular Penetration System (MiDROPS) consists of a library of thermodynamically stable micro-emulsions which can solubilize small molecules and even extremely lipophilic molecules which can ensure delivery to both the anterior and the posterior segment after topical delivery. EyeCRO has a wide range of in vivo models for studying the effects of drugs targeted against allergic conjunctivitis ,corneal neovascularization and wound healing, dry eye, inherited retinal degeneration, light damaged rodents and several others.
- Headquarters Oklahoma City, United States
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website eyecro.com
- Social LinkedIn X Facebook
- Latest Funding Round$185.55K (USD), Grant
Sep 2016
- Investors
Products & Services of EyeCRO
EyeCRO offers a comprehensive portfolio of products and services, including MiDROPS®, Preclinical Models, and Toxicology Services.
Microemulsion platform for eyedrop formulations of lipophilic drugs.
Models for testing eye diseases like dry eye and retinal disorders.
Studies for pharmacokinetics and safety in ophthalmic research.
Funding Insights of EyeCRO
- Total Rounds 19
- Last Round Grant — $185,550
- First Round $1.39M
(Sep 2006)
- Investors Count 1
Latest 10 of 19 funding rounds of EyeCRO with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2016 | $185,550 | Grant | – | – | – |
| Aug 2015 | $225,000 | Grant | – | – | – |
| Mar 2013 | $1.74M | Grant | – | – | – |
| May 2012 | $231,087 | Grant | – | – | |
| Apr 2012 | $231,087 | Grant | – | – | |
| Sep 2011 | $287,947 | Grant | – | – | |
| Aug 2011 | $287,947 | Grant | – | – | |
| Jul 2011 | $265,992 | Grant | – | – | |
| Jun 2011 | $265,992 | Grant | – | – | |
| Feb 2011 | $2.65M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in EyeCRO
EyeCRO has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for EyeCRO
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of EyeCRO
5 people are tracked at EyeCRO (5 in leadership).
| Name | Role | Group |
|---|---|---|
Connor Hodde, CPA | Vice President of Finance | Leadership |
Alexander Q. | Sr. Vice President | Leadership |
Rafal Farjo | Chief Executive Officer | Leadership |
Terry G. Coursey, PhD | Vice President, Science and Discovery | Leadership |
Phillip Vanlandingham, Ph.D. | Vice President of Translational Research | Leadership |
Complete people profiles for EyeCRO
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of EyeCRO
3 dated milestones of EyeCRO across 10 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round of $1.4M.
- Founded EyeCRO is founded.
- Funding Latest funding round, Grant, of $186K.
Competitors of EyeCRO
EyeCRO has 3 listed competitors in our database. They include Lexitas, Humonix Biosciences and Optimal Tracers.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lexitas.com | 2011 | Durham, United States | 106 | Clinical trials and medical strategies for ophthalmology products are provided. | ||
| humonixbio.com | 2014 | Albany, United States | CRO focused on ophthalmic drugs development services | |||
| optimaltracers.org | 2013 | Sacramento, United States | CRO focused on clinical research and tracer development services |
Detailed competitors of EyeCRO
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of EyeCRO
The website of EyeCRO (eyecro.com) receives about 1.9K visits a month and ranks #10,504,025 among all websites worldwide, #7,927 in Biotechnology and Pharmaceuticals.
- Monthly visits1.9K
▲ 13.8% vs previous month
- Global rank#10,504,025
among all websites
- Category rank#7,927
Health · Biotechnology and Pharmaceuticals
- Bounce rate45%
- Pages per visit1.2
- Average visit2 sec
- DevicesDesktop 43% · Mobile 57%
Websites whose visitors overlap most with EyeCRO. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| oraclinical.com | 100% | 8.4K | View details | ||
| iris-pharma.com | 100% | 2.2K | #10,426,473 | View details | |
smo-usa.com | smo-usa.com | 91% | – | ||
aceris.org | aceris.org | 83% | – | ||
| vivakor.com | 78% | 9.1K | #2,458,402 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for EyeCRO
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as EyeCRO (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Eyecro
Complete news archive for EyeCRO
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about EyeCRO
EyeCRO was founded in 2011.
EyeCRO is headquartered in Oklahoma City, United States. It is registered at Oklahoma City, Oklahoma, United States.
EyeCRO is a preclinical ophthalmic CRO whose primary offerings are retinal disease models. They specialize in ophthalmic studies of pharmacology, toxicology, efficacy, pharmacokinetics, and eyedrop formulation development. They offer their services in preclinical development areas such as formulation, study design, ocular surgery, veterinary, cell biology, and molecular biology. Their patent protected Microemulsion Drug Ocular Penetration System (MiDROPS) consists of a library of thermodynamically stable micro-emulsions which can solubilize small molecules and even extremely lipophilic molecules which can ensure delivery to both the anterior and the posterior segment after topical delivery. EyeCRO has a wide range of in vivo models for studying the effects of drugs targeted against allergic conjunctivitis ,corneal neovascularization and wound healing, dry eye, inherited retinal degeneration, light damaged rodents and several others.
EyeCRO's top competitors include Lexitas, Humonix Biosciences and Optimal Tracers.
EyeCRO offers MiDROPS®, Preclinical Models, and Toxicology Services.
EyeCRO has 1 investor. Key investors include HHS.